As the genomic regions containing loci predisposing to obesity-related traits are mapped in human population screens and mouse genetic studies, identification of susceptibility genes will be increasingly facilitated by bioinformatic methods. We hypothesized that candidate genes can be prioritized by their expression levels in tissues of central importance in obesity. Our objective was to develop a combined bioinformatics and molecular paradigm to identify novel genes as candidates for murine or human obesity genetic modifiers, based on their differential expression patterns in the hypothalamus compared to other murine tissues. We used bioinformatics tools to search publicly available gene expression databases using criteria designed to identify novel genes differentially expressed in the hypothalamus. We used RNA methods to determine their expression sites and levels of expression in the hypothalamus of the murine brain. We identified the chromosomal location of the novel genes in mice and in humans, and compared these locations to those of genetic loci predisposing to obesity-related traits. We developed a search strategy that correctly identified a set of genes known to be important in hypothalamic function, as well as a candidate gene for Prader-Willi syndrome that was not previously identified as differentially expressed in the hypothalamus. Using this same strategy, we identified and characterized a set of eleven genes not previously known to be differentially expressed in the murine hypothalamus. Our results demonstrate the feasibility of combined bioinformatics and molecular approaches to the identification of genes that are candidates for obesity-related disorders in humans and in mice.
Introduction
Obesity is a major health issue facing developed nations today. Despite years of population studies, the genetic determinants of healthy body weight are poorly understood (1) . Likewise, although there is increased understanding of the role of the hypothalamic-pituitary-adrenal axis in obesity, the proteins implicated in the development and/or function of this organ system are not all identified or characterized. Specific proteins, such as hormones and their receptors, are responsible for control of appetite and long-term maintenance of body weight (18, 24 ). An increasing number of studies rely on mapping obesity modifier loci in mice or humans, then choosing candidate genes within the mapped region for further study (19, 20) . Still other studies examine changes in gene expression in mice undergoing dietary challenges, or in obesity gene knockout versus wild type mice. Yet, the reliability of effective choice of candidate genes depends on there being prior knowledge of gene expression or function in searchable databases.
Often this knowledge exists, but is not readily available to researchers who are unfamiliar with the complexities of bioinformatics databases.
To search for obesity candidate genes, we used a combined bioinformatic and molecular biology approach to identify novel genes important to the function of the hypothalamus. The hypothalamus is a complex region of the brain involved in homeostatic processes including, but not limited to energy balance. We identified a set of genes already known to be important to hypothalamic function, and a set of genes not previously associated with the hypothalamus. We propose that these genes may be important in the function of the hypothalamus, may provide a new source of hypothalamus-specific regulatory elements, and may be important in disorders of hypothalamic function, such as obesity. Furthermore, genes identified in this search are now candidate genes for obesity related traits genetically mapped to the chromosomal intervals in which they reside.
Materials and Methods
Bioinformatics. The GNF murine gene expression atlas (now updated to GNF SymAtlas v1.0.3) was originally developed as a tool for high-throughput analysis of transcriptional activity in biological samples (25, 26) . The expression of specific genes within 45 diverse murine tissues, including the hypothalamus, was quantified by hybridization to Affymetrix mouse (U74A) high density oligonucleotide arrays, and made available as a searchable, online database. We filtered the murine dataset to select genes with levels of expression above the median in the hypothalamus, but with a moderately high level of expression above the median in no more than five other tissues. According to the GNF SymAtlas database, duplicate samples and/or duplicate hybridizations were performed for each tissue, and these values are integrated into the error bars for each measurement. Because of the configuration of the database, it is not possible to generate estimates of statistical significance; rather the search criteria were left deliberately broad at the risk of including some genes that do not in fact show as much specificity for hypothalamic expression when analyzed further as might be expected from the database search alone. The median is defined for the specific gene, across all tissues, so that there is no bias against genes that have low to moderate levels of gene expression overall. This first search was performed on the GeneAtlas Version 1 Dataset (25) . A second search was performed on the GeneAtlas Version 2 Dataset, Mouse GeneAtlas GNF1M (26) . In this data set, a correlation search was performed to identify genes with a high value in the hypothalamus (set at 400), any value in non-brain tissues, and a low value (set at 1) in other regions of the brain, with a correlation of 0.98. Because the preoptic region is part of the hypothalamus, we allowed any value for expression in the preoptic area as well. Genome localization for selected murine hypothalamic genes was identified from the May 2004 mouse (Mus musculus) draft genome data, Build 33 assembly by NCBI. Genomic localization of human orthologues was deduced using NCBI database UniGene and Gene.
Expression studies. RNA in situ hybridization was performed using digoxigenin-labeled antisense RNA probes on 20 µm cryosections of embryonic day 18.5 mouse embryos as previously described (16) . Probes for Hcrt, A26100, Dscr1l2, Impact, and Pnck were derived from PCR fragments amplified from reverse transcribed adult mouse hypothalamus mRNA with probe includes positions 984-1754 of Genbank accession number NM_013779 and was previously described (16) . All studies involving animals were performed according to the guidelines for the use and care of laboratory animals at the University of Alberta.
Results
A major goal of the Human Genome project was to identify expressed sequences (ESTs, expressed sequence tags) from RNA isolated from tissues or cell lines. By clustering the ESTs into groups (UniGene clusters) by sequence identity, the resulting UniGene database could be queried with a gene name to discover the tissues in which the gene is expressed. Until recently, there were no public databases that allowed investigators to perform the converse query, which is to discover the expression levels of all the transcripts in a particular tissue with respect to their expression levels in other tissues. However, the results of two large-scale gene array experiments documenting expression levels of most genes in a wide range of mouse tissues, including the hypothalamus, have recently been published. Specifically, labeled cDNA from each mouse tissue was hybridized to Affymetrix Genechip microarrays to profile expression levels of 36,000 genes in those tissues. In this study, multi-tissue comparisons were performed to normalize expression levels, and input into a searchable gene expression database (the GNF database) made available by the Novartis Research Foundation (8, 25). The major advantage over previous studies, which used subtractive methods to derive hypothalamic cDNAs, is that levels of expression can be compared between tissues and between parts of the brain, so that genes expressed more highly or more specifically in the hypothalamus can be easily identified.
We queried this database to identify genes differentially expressed in the murine adult hypothalamus.
Strategy for identification of hypothalamic transcripts. We reasoned that genes important in hypothalamic development or function are likely to be transcribed in hypothalamic precursor tissues or the mature hypothalamus. The laboratory mouse is a model particularly amenable to studies of brain function, because of similarities in anatomy to the human hypothalamus and because of its widespread use in obesity studies. We performed three searches using different criteria to query the GNF expression database for genes highly expressed in the postnatal murine hypothalamus. Our first search of the GNF database used low specificity criteria that required only high expression in hypothalamus, of at least eight times the median of the expression level in all 45 mouse tissues. This search identified a set of genes already studied for their role in hypothalamic function, such as pro-opiomelanocortin-alpha and hypocretin, but also identified many genes broadly expressed in the nervous system, such as the microtubule-associated protein tau. Notably, some genes important in obesity and/or hypothalamic function were not identified under these conditions (e.g. the widely expressed Nhlh2). Our second search of the GNF database used high specificity criteria as that for the first search, high expression in the hypothalamus of at least eight times the median of the expression in other tissues. In addition, the second search required low expression (less than three times the median) in at least 40 other tissues. This second search identified five genes including arginine vasopressin, POMC, hypocretin and oxytocin, all of which have major roles in endocrine regulation in the hypothalamus. Significantly, this high specificity search also identified Magel2, which is developmentally regulated and inactivated in the genetic obesity disorder Prader-Willi syndrome.
We then formulated a third search with intermediate specificity: expression in the hypothalamus over eight times the median level of all tissues, and fewer than five tissues with over three times the median level of expression. The third search of the GNF database identified a set of fifteen genes highly expressed in the hypothalamus, but moderately to highly expressed in only five other murine tissues (Table 1 , screen 1). We repeated the third search using an updated database, the 2004 version of the mouse Geneatlas. As with the third search of the GNF database, the search of Geneatlas 2004 identified genes with high expression in the hypothalamus, and low expression elsewhere in the brain. We then used the correlation function of the searchable Symatlas database, within Geneatlas. The Symatlas search was refined to allow either high or low expression in the preoptic region, which functionally overlaps with the hypothalamus. This last search, still using intermediate specificity criteria, identified seven genes, three of which were identified in the GNF intermediate specificity search (Table 1 , screen 2), for a total of nineteen genes.
Selection of novel hypothalamic genes. Of the nineteen genes from the two searches of the GNF databases, three genes were identified in both searches (Table 1 Gene expression profiles. The remaining eleven genes fell into two categories: novel genes for which a function has been predicted by sequence similarity to known genes, and novel genes with no known function and no or limited similarity to known genes ( Table 2) . We examined the UniGene clusters associated with these novel genes. As EST sets made from hypothalamus RNA are represented in the mouse EST databases, we expected to see representation of hypothalamic cDNAs within the Unigene clusters corresponding to these genes. Indeed, all eleven genes had corresponding ESTs derived from whole brain, with some specifically including hypothalamus (4) or diencephalon (2) ( Table 2 ). The information in the UniGene clusters did not point to these genes being particularly hypothalamus-specific, in contrast to the RNA in situ hybridization. We first verified that the eleven selected genes were indeed expressed in the murine hypothalamus, by reverse transcription PCR on RNA samples from the adult mouse hypothalamus (data not shown). We then localized the expression to specific hypothalamic nuclei by RNA in situ hybridization, using a standard mouse atlas to label the sections (13) . A probe for Hcrt displayed a strong signal in the lateral anterior hypothalamus, consistent with the known abundance of RNA transcripts in this region of the brain (Fig. 1 ) (27).
Consistent with the earlier embryonic expression of Magel2 in the suprachiasmatic nucleus (16),
we detected Magel2 transcripts in the anterior hypothalamus and suprachiasmatic nucleus (Fig.   1 ). We then selected four genes that emerged from the bioinformatic analysis but about which little else was known. All four genes displayed high levels of expression in the hypothalamus compared to surrounding brain tissue by RNA in situ hybridization (Fig. 1) . Probes for A2610042L04 and Pnck detected abundant expression in the anterior hypothalamus, while a probe for Dscr1l2 detected strongest expression in the dorsal medial hypothalamus, ventromedial hypothalamus, and arcuate nucleus, and a probe for Impact detected highest expression in the arcuate nucleus.
Gene mapping. We used the NCBI databases to map the eleven selected genes to chromosomal regions in the mouse genome (NCBI Build 33) and human genome (NCBI Build 35) ( Table 3) .
We then correlated the map positions of selected genes with the genomic positions of published loci influencing obesity related traits in either human or other mammals (23) ( Table 3) , updated and published on-line as "The Obesity Gene Map Database" (19). We identified eight traits, such as body mass index, fat mass, and % body fat that had been mapped to the same chromosomal regions as our selected genes in human studies of weight gain and obesity. We then identified cases where obesity traits had been identified as mapping within the mouse, rat or pig chromosomal region homologous to human chromosome band(s) containing the selected genes. We did not include traits that had been mapped to an interval that contained more than three chromosome bands, which would contain a very large number of candidate genes. In this way, we identified thirteen obesity-related traits in the mouse (11), rat (1), or pig (1) that correlated to the map positions of six of the eleven selected genes; these traits were all related to obesity and weight gain. Except for A2610042L04, a poorly characterized predicted mouse gene on chromosome 14, all selected genes were in regions of a mammalian genome where genetic evidence for an obesity-related trait exists.
Discussion.
The use of microarray-based systems has accelerated high-throughput gene expression profiling in tissues of interest in disease processes. Previous studies designed to identify cDNAs enriched in the hypothalamus used subtractive hybridization (7) or EST cataloguing (12) .
Although these methods did identify genes expressed in the hypothalamus, there are intrinsic biases towards highly expressed genes in both methods; subtractive hybridization methodologies can also have intrinsic sequence-specific biases. In contrast, high-throughput gene expression profiling provides a robust, unbiased, searchable resource that is freely available to the research community. We examined the relative expression levels of an estimated 30,000 genes in the murine hypothalamus as determined by Affymetrix microarray technology and made available by the Novartis Research Foundation (8) . From this, we identified a set of genes not previously recognized to be important in hypothalamic function, but highly and preferentially expressed in the murine hypothalamus. It is exciting to think that if such a database had been available at the time that we cloned Magel2 in 1999, this analysis could have facilitated the selection of human MAGEL2 as a candidate gene for the extreme obesity seen in Prader-Willi syndrome.
We have identified eleven genes whose expression is enriched in the hypothalamus, but which were not previously associated with the development of the hypothalamus or its function.
The candidate genes could be involved in any number of the interrelated processes partially mediated by the hypothalamus besides energy and fluid balance, such as circadian rhythm, reproduction, stress responses, and temperature regulation (1) . The definitive proof of their involvement in obesity, rather than in other functions of the hypothalamus, would come from a demonstration of gene dysregulation in various models of obesity, including genetic and dietinduced obesity. We concentrated on obesity because of the large number of studies providing genetically mapped obesity-related traits, but the genes that we identified could equally well have roles in other disorders of hypothalamic function. Other regions of the brain, including the cortex and hindbrain, have important roles in food intake (22), but have major roles in other neurological functions. The gut, liver, pancreas, and adipose tissues also have major roles in appetite, and parallel studies could reveal novel obesity susceptibility genes that are highly and specifically expressed in those tissues, but not expressed in the brain and hypothalamus.
Since susceptibility to obesity is in part genetically determined, variations in these genes may contribute to familial obesity. The information available about the cellular and physiological function of the proteins encoded by these genes is, however, highly variable.
Furthermore, the size of the intervals in which obesity traits have been mapped is also highly variable. Further genetic and molecular studies would clarify possible roles of the candidate genes in obesity. For example, the candidate gene located within the region where specific mouse strains or human subjects have shown genetic predisposition to obesity could be sequenced for coding or regulatory sequence variants. These variants could then be tested in larger populations for association with obesity-related traits, including traits genetically mapped to the chromosomal intervals in which the genes reside. Finally, further investigations of the physiological and cellular functions of the proteins identified in this and other bioinformatics screens may elucidate the role of specific genes and gene products in hypothalamic function and genetic predisposition to obesity. Intermediate specificity criteria were: expression in the hypothalamus > 8 times median level in other tissues AND fewer than 5 tissues with over 3 times the median level of expression. This screen was performed once on the GNF database (screen #1) and then again on the Geneatlas database (screen #2). 
